How GLP-1 medications are actually delivered
Direct answer
What you need to know
Evidence strength: StrongGLP-1 receptor agonists come in exactly two approved forms: injection and oral tablet. Both require a prescription. Patches, gummies, and drops sold as “GLP-1” products contain no GLP-1 medication — they borrow the name of a drug they do not contain.
Key takeaways
- Injection is the format every pivotal trial used.
- Oral tablets are real and now number three: Rybelsus, Wegovy tablets, and Foundayo.
- There is no approved patch, gummy, or drop, in any country we could verify.
- The simplest test: a real GLP-1 medication cannot be bought without a prescription.
Important limitation: Supplement products are not necessarily harmful, and some of their ingredients have modest research behind them. The claim being made here is narrower: they are not the medication, and should not be judged against trial results for the medication.
Next action: If injections are the barrier, an oral tablet is the real alternative — discuss it with a prescriber. Our provider directory compares who prescribes what.
Primary sources: DailyMed, U.S. National Library of Medicine, U.S. Food & Drug Administration, Bos JD, Meinardi MM — Experimental Dermatology, 2000 (PMID 10839713), U.S. Food & Drug Administration
General education, not medical advice. We do not test products or review specific brands.
Every format, and whether it delivers the drug
| Format | Status | Delivers a GLP-1 receptor agonist? |
|---|---|---|
| Injection (pen or vial) | FDA-approved | Yes — this is the format every pivotal trial used. |
| Oral tablet | FDA-approved | Yes — three FDA-approved oral options now exist. |
| Transdermal patch | Contains no GLP-1 drug | No. There is no FDA-approved GLP-1 patch, and the chemistry is against it. |
| Gummies | Contains no GLP-1 drug | No. These are dietary supplements containing no GLP-1 drug. |
| Oral drops and tinctures | Contains no GLP-1 drug | No — with a more dangerous edge case. |
The formats that are real
Injection (pen or vial). Weekly subcutaneous injection is how semaglutide and tirzepatide were studied and approved. Wegovy, Ozempic, Zepbound, Mounjaro, and Saxenda are all injectables.
Oral tablet. Rybelsus (oral semaglutide, for type 2 diabetes), Wegovy tablets (for weight management), and Foundayo (orforglipron, approved April 2026) are genuine, prescription-only oral GLP-1 medications. This is the one non-injectable format that is real.
The formats that use the name
Transdermal patch. Semaglutide is roughly eight times heavier than the largest molecule that passively crosses intact skin. Products sold as GLP-1 patches contain no GLP-1 receptor agonist.
Gummies. Typically berberine, cinnamon, apple cider vinegar, probiotics, or fibre. Sellers generally do not claim these contain semaglutide — they claim to 'support' your body's own GLP-1, which is a different and much weaker claim.
Oral drops and tinctures. Most are supplements like the gummies. But some liquids sold online are unapproved semaglutide labelled 'for research purposes only' or 'not for human consumption', which the FDA has issued warning letters over.
The useful question is not “does this format work?” but “does this product contain the drug at all?” For patches, gummies, and drops, the answer is almost always no — and that is checkable before you spend anything.
Why this distinction is worth the trouble
“GLP-1” has become two different things: a class of prescription medicines, and a marketing word. A supplement can legally say it “supports GLP-1” without containing any, because that is a structure/function claim rather than a drug claim. The gap between those two sentences is where most of this market lives.
The trial figures people have in mind when they buy these products — the 14.9% and 22.5% body-weight reductions — come from injections and tablets at approved doses. Those figures and their sources are on our statistics page. They do not transfer to a patch.